Company Filing History:
3 out of 560 
2 out of 666 
1 out of 2,886 
Years Active: 2023-2024
Title: Innovations in Cancer Treatment by Samuel F. Bakhoum
Introduction
Samuel F. Bakhoum is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 3 patents, his work focuses on enhancing the effectiveness of radiation therapy for cancer patients.
Latest Patents
Bakhoum's latest patents include groundbreaking methods and compositions aimed at increasing the susceptibility of cancer cells to radiation treatment. One of his notable inventions involves a method for delivering radiosensitizing agents that disrupt chromosome segregation, thereby increasing chromosome missegregation in cancer cells. This approach targets specific proteins involved in maintaining chromosome stability, which can enhance the effectiveness of radiation therapy.
Another significant patent addresses the detection and treatment of metastatic cancer by utilizing chromosomal missegregations and cytosolic DNA as indicators. His methods incorporate kinesin-13 proteins and various inhibitors to identify effective compounds for cancer treatment. These innovations represent a promising advancement in the fight against cancer.
Career Highlights
Samuel F. Bakhoum has worked at prestigious institutions such as Memorial Sloan Kettering Cancer Center and Dartmouth College. His research has garnered attention for its potential to improve cancer treatment outcomes and provide new avenues for therapeutic interventions.
Collaborations
Throughout his career, Bakhoum has collaborated with esteemed colleagues, including Bassem I. Zaki and Duane A. Compton. These partnerships have contributed to the advancement of his research and the development of innovative cancer treatment strategies.
Conclusion
Samuel F. Bakhoum's contributions to cancer treatment through his patented innovations highlight the importance of research in improving patient outcomes. His work continues to pave the way for new therapeutic approaches in oncology.